In the last decades, the incidence of oral squamous cell carcinoma (OSCC) has been constantly increasing, yet the survival outcomes have remained essentially unchanged. This, in part, is due to a lack of efficient, non-complex and rapid diagnostic and prognostic tools.
Recently, circulating miRNAs have emerged as a very effective biomarkers amenable to non-invasive liquid biopsies such as saliva sample.
The present invention analyzed a global salivary miRNA expression profile in OSCC patients and healthy subjects which led to the identification and validation in clinical setting of certain miRNAs as reliable biomarkers for OSCC. In contrast to solid biopsies, saliva ones have a potential to provide an an overall view of OSCC tumor heterogeneity thus be more accurate in disease screening, diagnosis and prognosis. The invention has a potential to stratify patients according to their likelihood of relapse.

TRL (Technology Readiness Level)

TRL 5 / 9

Inventors

Romualdi
Chiara

Salviato
Elisa

Nicolai
Piero

Romani
Chiara

Rossi
Paolo

Bignotti
Eliana

Paderno
Alberto

Download the brochure

  • Diagnostic kit for inflammatory bowel diseases

    Inflammatory bowel diseases, namely, Crohn’s disease and ulcerative colitis, are difficult to diagnose in a timely manner due to generic symptoms and lack of precise and reliable diagnostic methods priming for disease complications and colorectal cancer development. Current methods are[...]

  • Multifunctional nanoparticles based on metal nanalloys for diagnostic and therapeutic uses

    The invention relates to nanoparticles (NPs) comprising a metal alloy and a biocompatible organic stabilizer, useful in the diagnosis and therapy of pathological conditions such as cancer. The alloy NPs possess the characteristics required to be employed as contrast agents[...]

  • Three-dimensional mapping for melanoma diagnosis

    This apparatus can map the skin of patients who visit a dermatologist for early stage melanoma screening. The system can recognize and evaluate the moles with a risk of developing melanoma. The 3D information it gathers is crossed with a[...]

Subscribe to newsletter

Follow the activities promoted by UniSMART Foundation